What is Calibrate Health, Inc.?
Headquartered in New York City, Calibrate Health, Inc. operates as a specialized telemedicine platform dedicated to metabolic health and sustainable weight loss. By integrating clinical expertise with digital tracking tools, the company provides a comprehensive, evidence-based approach to health management that addresses the root causes of metabolic dysfunction. The firm occupies a pivotal niche in the healthcare sector, bridging the gap between traditional clinical care and the convenience of modern digital health platforms. Its market position is defined by a focus on long-term outcomes rather than temporary solutions, a strategy that has resonated with both patients and institutional investors seeking to disrupt the status quo of chronic disease management.
How much funding has Calibrate Health, Inc. raised?
Calibrate Health, Inc. has raised a total of $127.6M across 3 funding rounds:
Angel/Seed
$5.1M
Series A
$22.5M
Series B
$100M
Angel/Seed (2020): $5.1M with participation from Forerunner Ventures
Series A (2021): $22.5M led by Threshold Ventures, Redesign Health, and Forerunner Ventures
Series B (2021): $100M supported by Tiger Global Management, Founders Fund, Optum Ventures, and Threshold Ventures
Key Investors in Calibrate Health, Inc.
Tiger Global Management
Tiger Global Management is a prominent investment firm that deploys significant capital across both public and private markets, focusing on high-growth technology and consumer-facing companies.
Founders Fund
Founders Fund is a venture capital firm that invests in transformative companies across all stages, known for supporting founders who aim to build the most valuable and impactful businesses in their respective sectors.
Optum Ventures
Optum Ventures is the venture capital arm of Optum, dedicated to investing in early-stage companies that are poised to disrupt the healthcare status quo and improve health outcomes for all.
What's next for Calibrate Health, Inc.?
With the recent influx of capital, Calibrate Health, Inc. is well-positioned to accelerate its product development roadmap and expand its clinical network. The strategic focus will likely center on enhancing the platform's proprietary technology stack to improve patient engagement and clinical efficacy. Furthermore, the company is expected to leverage its strong balance sheet to pursue aggressive market penetration, potentially exploring new partnerships with health systems and insurance providers to integrate its services into broader care delivery models. As the firm matures, the emphasis will shift toward maintaining high-quality clinical outcomes while scaling operations to meet the growing demand for accessible, personalized metabolic health services.
See full Calibrate Health, Inc. company page
